Celldex Therapeutics
CLDX
#4531
Rank
$1.29 B
Marketcap
$27.48
Share price
-0.16%
Change (1 day)
-11.49%
Change (1 year)

Earnings for Celldex Therapeutics (CLDX)

Earnings in 2023 (TTM): -$0.13 B

According to Celldex Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.13 B. In 2022 the company made an earning of -$0.11 B a decrease over its 2021 earnings that were of -$69.15 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Celldex Therapeutics from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM)-$0.13 B13.22%
2022-$0.11 B54.88%
2021-$69.15 M39.49%
2020-$49.58 M-9.08%
2019-$54.53 M-28.64%
2018-$76.41 M-30.11%
2017-$0.11 B-17.75%
2016-$0.14 B2.61%
2015-$0.13 B9.71%
2014-$0.12 B46.46%
2013-$80.63 M
2011-$43.01 M3492.65%
2010-$1.2 M-96.73%
2009-$36.61 M
2006-$22.37 M18.56%
2005-$18.87 M38.89%
2004-$13.59 M15.75%
2003-$11.74 M-18.69%
2002-$14.44 M-41.22%
2001-$24.56 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$24.22 B-20,074.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.19 B-7,683.89%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.96 B-6,672.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$8.47 M-93.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.76 B 520.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.21 B 69.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.48 B 294.70%๐Ÿ‡บ๐Ÿ‡ธ USA